Search - tctmd.com

Displaying 21 - 40 of 139

Sort: Relevancy | Date

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Conference News EuroPCR 2022

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Caitlin E. Cox

May 17, 2022

News Conference News STS 2022

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

Todd Neale

February 02, 2022

News Daily News

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

L.A. McKeown

November 30, 2021

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

News Daily News

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

Michael O'Riordan

October 01, 2021

News Daily News

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

L.A. McKeown

September 22, 2021

Excluded from Pivotal Trials, Low-risk Complex Patients Warrant Caution

News Daily News

Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution

L.A. McKeown

January 22, 2021

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

Presentation TCT 2020

Five-Year Follow-Up from the PARTNER 2 Aortic Valve-in-Valve Registries: Clinical Outcomes, Valve Function, and Durability

Presenter: Rebecca T. Hahn

October 17, 2020

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Evidence Updates From PARTNER 3

Presenter: Martin Leon

October 16, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Daily News

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

Caitlin E. Cox

September 14, 2020

News Daily News

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

L.A. McKeown

August 17, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Conference News CRT 2020

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

L.A. McKeown

February 24, 2020

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

Advertisement

What’s Going to Be Hot at ESC 2022?

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Five-Year Follow-Up from the PARTNER 2 Aortic Valve-in-Valve Registries: Clinical Outcomes, Valve Function, and Durability

TAVR in Low Surgical Risk Patients - Evidence Updates From PARTNER 3

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content